Clinical Trial Update: Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical-trial update notes the evaluation of Axatilimab in combination with Retifanlimab and Paclitaxel for advanced or metastatic solid tumors, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Neoplasm

Drugs mentioned

• Axatilimab (axatilimab)
• PACLITAXEL (PACLITAXEL)
• Retifanlimab (retifanlimab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1, Phase 2 | Status: RECRUITING